Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
MOTS-c: Evidence Summary
Evidence summary for MOTS-c across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to MOTS-c overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Metabolic regulation | Tier C | 1 | Mitochondria-derived peptide improves glucose homeostasis in early human studies |
| Insulin sensitivity | Tier C | 1 | Improved glucose disposal in obese subjects in pilot study |
| Exercise mimetic | Tier D | 0 | Activates AMPK and enhances fatty acid oxidation in preclinical models |